Individual and population-level variability in HLA-DR associated immunogenicity risk of biologics used for the treatment of rheumatoid arthritis. - Sugiyama N; Terry FE; Gutierrez AH; Hirano T; Hoshi M; Mizuno Y; Martin W; Yasunaga S; Niiro H; Fujio K; De Groot AS (Frontiers in immunology, 2024)